Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

NCT04699123 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04699123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04699123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 4, 2021
Completion date
December 30, 2026
Enrollment
159 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-small cell lung cancer